Dr. Shenoy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 N Broad St
Philadelphia, PA 19140Phone+1 215-707-5864Fax+1 215-707-6867
Summary
- Dr. Kartik Shenoy, based in Philadelphia, PA, is a pulmonologist with subspecialties in Asthma & COPD, Critical Care Medicine, Lung Transplantation Medicine, and Pleural Disease. He completed his medical education at Northeast Ohio Medical University in 2005, followed by residency and fellowship in Internal Medicine, Pulmonary Disease, and Critical Care Medicine at Temple University Hospital. Dr. Shenoy has considerable experience in treating asthma, COPD, transplant pulmonology, interstitial lung disease, and critical care conditions. He has published several significant papers pertaining to his specialty areas in respected journals, including 'The Journal of Allergy and Clinical Immunology' and 'Transplantation.' In addition to this, he has also contributed to the medical field through his participation in clinical trials on asthma treatment and management.
Education & Training
- Temple University HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
- Temple University HospitalResidency, Internal Medicine, 2005 - 2008
- Northeast Ohio Medical UniversityClass of 2005
Certifications & Licensure
- PA State Medical License 2008 - 2026
- NJ State Medical License 2019 - 2021
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) Start of enrollment: 2010 Nov 01
- Efficacy and Safety Study of Benralizumab to Reduce OCS Use in Patients With Uncontrolled Asthma on High Dose Inhaled Corticosteroid Plus LABA and Chronic OCS Therapy Start of enrollment: 2014 Apr 28
- A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA Start of enrollment: 2014 Nov 19
Publications & Presentations
PubMed
- Asthma morbidity measures across Black ethnic subgroups.Leah Ishmael, Andrea Apter, Paula J Busse, Rafael Calderon-Candelario, Jennifer K Carroll
The Journal of Allergy and Clinical Immunology. 2024-02-01 - 5 citationsCritical Care Management of Severe Asthma Exacerbations.Shameek Gayen, Stephen Dachert, Bilal H Lashari, Matthew Gordon, Parag Desai
Journal of Clinical Medicine. 2024-02-01 - Preference for and impact of telehealth vs in-person asthma visits among Black and Latinx adults.Israel C Ugalde, Amanda Ratigan, Conner Merriman, Jing Cui, Brianna Ericson
Annals of Allergy, Asthma & Immunology. 2023-11-01
Press Mentions
- Using Innovative Research to Drive New Opportunities for Lung TreatmentsFebruary 1st, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: